Open Access
Feature Article

The cardiac complications of obesity

Open Access
Feature Article

The cardiac complications of obesity

Elizabeth Paratz, Sonny Palmer, Justin Mariani

Figures

© LIGHTSPRING/SHUTTERSTOCK
© LIGHTSPRING/SHUTTERSTOCK
Dr Paratz is a Cardiologist at St Vincent’s Hospital and the Baker Heart & Diabetes Institute, Melbourne. Associate Professor Palmer is an Interventional and Structural Cardiologist at St Vincent’s Hospital, Melbourne. Associate Professor Mariani is an Interventional Heart Failure Specialist at The Alfred Hospital, Melbourne, Vic.

 

Advertisement

References 

1.     Australian Institute of Health and Welfare. Data tables: Overweight and obesity 2019. Available online at: www.aihw.gov.au/reports-data/behaviours-risk-factors/overweight-obesity/data (accessed September 2020).
2.    Twaij A, Sodergren MH, Pucher PH, et al. A growing problem: implications of obesity on the provision of trauma care. Obes Surg 2013; 23: 2113-2120.
3.    Access Economics. The growing costs of obesity in 2008: three years on. Canberra: Diabetes Australia; 2008. Available online at: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/7b855650-e129-4499-a371-c7932f8cc38d.pdf (accessed September 2020).
4.    Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260. 
5.    Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first non-ST-segment myocardial infarction. J Am Coll Cardiol 2008; 52: 979-985.
6.    Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease:  risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-1932.
7.    Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007; 29: 98-114.
8.    Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and hypertension in obesity. Vasc Health Risk Manag 2006; 2: 163-169. 
9.    National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia (2013). Canberra: NHMRC; 2013.
10. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes – 3-year outcomes. N Engl J Med 2014; 370: 2002-2013.
11. Head GA. Cardiovascular and metabolic consequences of obesity. Front Physiol 2015; 6: 32.
12. Ding D, Chong S, Jalaludin B, Comino E, Bauman AE. Risk factors of incident type 2-diabetes mellitus over a 3-year follow-up: results from a large Australian sample. Diabetes Res Clin Pract 2015; 108: 306-315.
13. Nyström PK, Carlsson AC, Leander K, de Faire U, Hellenius ML, Gigante B. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One 2015; 10(5): e0127111.
14. Pathak RK, Mahajan R, Lau DH, et al. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol 2015; 31: 203-210.
15. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56-65. 
16. Basoor A, Cotant JF, Randhawa G, et al. High prevalence of obesity in young patients with ST elevation myocardial infarction. Am Heart Hosp J 2011; 9: 37-40.
17. Plourde B, Sarrazin JF, Nault I, Poirier P. Sudden cardiac death and obesity. Exp Rev Cardiovasc Ther 2014; 12: 1099-1110.
18. Zimmet P. Diabesity in Australia: an affair of the heart. Heart Lung Circ 2003; 12 Suppl 2: S95-S98.
19. Reddy YN, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circ 2018; 138: 861-870.
20. Kitzman DW, Shah SJ. The HFpEF obesity phenotype: the elephant in the room. J Am Coll Cardiol 2016; 68: 200-203.
21. Kitzman DW, Lam CS. Obese heart failure with preserved ejection fraction phenotype: from pariah to central player. Circ 2017; 136: 20-23.
22. Adabag S, Huxley RR, Lopez FL, et al. Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study. Heart 2015; 101: 215-221.
23. Chen H, Deng Y, Li S. Relation of body mass index categories with risk of sudden cardiac death. Int Heart J 2019; 60: 624-630.
24. Noheria A, Teodorescu C, Uy-Evanado A, et al. Distinctive profile of sudden cardiac arrest in middle-aged vs. older adults: a community-based study. Int J Cardiol 2013; 168: 3495-3499.
25. Alpert MA, Terry BE, Cohen MV, et al. The electrocardiogram in morbid obesity. Am J Cardiol 2000; 85: 908-910.
26. Lim SP, Arasaratnam P, Chow BJ. Obesity and the challenges of non-invasive imaging for the detection of coronary artery disease. Can J Cardiol 2015; 31: 223-226. 
27. Buschur ME, Smith D, Share D, et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol 2013; 62: 685-691.
28. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment and in-hospital outcomes of 50,149 patients with ST-segment myocardial infarction. J Am Coll Cardiol 2011; 58:  2642-2650.
29. Payvar S, Kim S, Rao SV, et al. In-hospital outcomes of percutaneous coronary interventions in extremely-obese and normal-weight patients. J Am Coll Cardiol 2013; 62: 692-696.
30. McNulty PH, Ettinger SM, Field JM, et al. Cardiac catheterization in morbidly obese patients. Cathet Cardiovasc Intervent 2002; 56: 174-177.
31. Yap CH, Mohajeri M, Yii M. Obesity and early complications after cardiac surgery. Med J Aust 2007; 186: 350-354.
32. Wigfield CH, Lindsey JD, Munoz A, et al. Is extreme obesity a risk factor for cardiothoracic surgery? An analysis of patients with a BMI>40. Eur J Cardiothor Surg 2006; 29: 434-440. 
33. Choi JC, Bakaeen FG, Cornwell LD, et al. Morbid obesity is associated with increased resource utilization in coronary artery bypass grafting. Ann Thorac Surg 2012; 94: 23-28.
34. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:  1567-1576.
35. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 2017; 70: 2022-2035.
36. Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY study). J Am Coll Cardiol 2015; 65: 2159-2169.
37. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardio-metabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 2013; 310: 2050-2060.
38. Piché MÈ, Auclair A, Harvey J, Marceau S, Poirier P. How to use and choose bariatric surgery in 2015. Can J Cardiol 2015; 31: 153-166.
39. Poirier P, McCrindle BW, Leiter LA. Obesity: it must not remain the neglected risk factor in cardiology. Can J Cardiol 2015; 31: 105-108.
40. Shimada YJ, Gibo K, Tsugawa Y, et al. Bariatric surgery is associated with lower risk of acute care use for cardiovascular disease in adults. Cardiovasc Res 2019; 115: 800-806.
41. Lim J, Cho YH, Yamamoto H, Eng A, Markovic T, Kim KK. Governmental or social support of bariatric surgery in the asia-pacific region. J Obes Metab Syndr 2017; 26: 10-14.